[1]Blüher S, Schwarz P. Metabolically healthy obesity from childhood to adulthood-Does weight status alone matter? Metabolism, 2014, 63(9): 1084-1092 [2]Wildman RP. Healthy obesity. Curr Opin Clin Nutr Metab care, 2009, 12(4): 438-443 [3]Iacobini C, Pugliese G, Blasetti Fantauzzi C, et al. Metabolically healthy versus metabolically unhealthy obesity. Metabolism, 2019, 92: 51-60 [4]Samocha-Bonet D, Dixit VD, Kahn CR, et al. Metabolically healthy and unhealthy obese-the 2013 Stock Conference report. Obes Rev, 2014, 15(9): 697-708 [5]Samocha-Bonet D, Chisholm DJ, Tonks K, et al. Insulin-sensitive obesity in humans-a 'favorable fat' phenotype? Trends Endocrinol Metab, 2012, 23(3): 116-124 [6]Blüher M, Mantzoros CS. From leptin to other adipokines in health and disease: Facts and expectations at the beginning of the 21st century. Metabolism, 2015, 64(1): 131-145 [7]Saukkonen T, Mutt SJ, Jokelainen J, et al. Adipokines and inflammatory markers in elderly subjects with high risk of type 2 diabetes and cardiovascular disease. Sci Rep, 2018, 8(1): 12816 [8]Shibata R, Ouchi N, Ohashi K, et al. The role of adipokines in cardiovascular disease. J Cardiol, 2017, 70(4): 329-334 [9] Poulos SP, Hausman DB, Hausman GJ. The development and endocrine functions of adipose tissue. Mol Cell Endocrinol, 2010, 323(1): 20-34 [10]中国肥胖问题工作组. 中国学龄儿童青少年超重 肥胖筛查体重指数值分类标准. 中华流行病学杂志, 2004, 25(2): 97-102 [11]米杰, 王天有, 孟玲慧, 等. 中国儿童青少年血压参照标准的研究制定. 中国循证儿科杂志, 2010, 5(1): 4-14 [12]中华医学会儿科学分会内分泌遗传代谢学组, 中华医学会儿科学分会心血管学组, 中华医学会儿科学分会儿童保健学组, 等. 中国儿童青少年代谢综合征定义和防治建议. 中华儿科杂志, 2012, 50(6): 420-422 [13]Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocr Metab, 2004. 89(6): 2526-2539 [14]Yin J, Li M, Xu L, et al. Insulin resistance determined by Homeostasis Model Assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers. Diabetol Metab Syndr, 2013, 5(1): 71 [15]Liu C, Wang C, Guan S, et al. The Prevalence of Metabolically Healthy and Unhealthy Obesity according to Different Criteria. Obes Facts, 2019, 12(1): 78-90 [16]Fu J, Li Y, Esangbedo IC, et al. Circulating Osteonectin and Adipokine Profiles in Relation to Metabolically Healthy Obesity in Chinese Children: Findings From BCAMS. J Am Heart Assoc, 2018, 7(23): e009169 [17]Estrella ML, Pirzada A, Durazo-Arvizu RA, et al. Correlates of and Body Composition Measures Associated with Metabolically Healthy Obesity Phenotype in Hispanic/Latino Women and Men: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL). J Obes, 2019: 1251456 [18]Antonisamy B, Vasan SK, Geethanjali FS, et al. Weight Gain and Height Growth during Infancy, Childhood, and Adolescence as Predictors of Adult Cardiovascular Risk. J Pediatr, 2017, 180: 53-61, e3 [19]Juhola J, Magnussen C G, Viikari J S A, et al. Tracking of Serum Lipid Levels, Blood Pressure, and Body Mass Index from Childhood to Adulthood: The Cardiovascular Risk in Young Finns Study. J Pediatr, 2011, 159(4): 584-590 [20]Olson M, Chambers M, Shaibi G. Pediatric Markers of Adult Cardiovascular Disease. Curr Pediatr Rev, 2017, 13(4): 255-259 [21]Yanai H, Yoshida H. Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives. Int J Mol Sci, 2019, 20(5): E1190 [22]Arslanian S, El Ghormli L, Bacha F, et al. Adiponectin, Insulin Sensitivity, beta-Cell Function, and Racial/Ethnic Disparity in Treatment Failure Rates in TODAY. Diabetes Care, 2017, 40(1): 85-93 [23]Mi J, Munkonda MN, Li M, et al. Adiponectin and Leptin Metabolic Biomarkers in Chinese Children and Adolescents. J Obes, 2010: 892081 [24]Jaakkola JM, Pahkala K, Viitala M, et al. Association of Adiponectin with Adolescent Cardiovascular Health in a Dietary Intervention Study. J Pediatr, 2015, 167(2): 353-360 [25]Vettor R, Milan G, Rossato M, et al. Review article: adipocytokines and insulin resistance. Aliment Pharm Ther, 2005, 22 Suppl 2: 3-10 [26]Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf), 2006, 64(4): 355-365 [27]郭皖北, 车志宏, 徐爱民, 等. 代谢综合征患者血清脂联素和血管生成素样蛋白3水平的变化及意义. 中南大学学报(医学版), 2010, 35(3): 203-208 [28]Zhang H, Niu Y, Gu H, et al. Low serum adiponectin is a predictor of progressing to nonalcoholic fatty liver disease. J Chin Lab Anal, 2018, 33(3): e22709 [29]周雪莲, 傅君芬. 儿童非酒精性脂肪肝病诊断与治疗专家共识. 中国实用儿科杂志, 2018, 33(7): 487-492 [30]Vorwieger E, Kelso A, Steinacker JM, et al. Cardio-metabolic and socio-environmental correlates of waist-to-height ratio in German primary schoolchildren: a cross-sectional exploration. Bmc Public Health, 2018, 18(1): 280 [31]Dong B, Wang Z, Arnold LW, et al. Simplifying the screening of abdominal adiposity in Chinese children with waist-to-height ratio. Am J Hum Biol, 2016, 28(6): 945-949 [32]Jiang J, Lin M, Xu Y, et al. Circulating neuregulin 4 levels are inversely associated with subclinical cardiovascular disease in obese adults. Sci Rep, 2016, 6: 367 [33]Wang G, Zhao X, Meng Z, et al. The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. Nat Med, 2014, 20(12): 1436-1443 [34] Dai Y, Zhu J, Fang Z, et al. A case-control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease. Metabolism, 2015, 64(12): 1667-1673 [35] Ma Y, Gao M, Liu D. Preventing High Fat Diet-induced Obesity and Improving Insulin Sensitivity through Neuregulin 4 Gene Transfer. Sci Rep, 2016, 6: 26242. [36]Farooqi IS, O'Rahilly S. 20 YEARS OF LEPTIN: Human disorders of leptin action. J Endocrinol, 2014, 223(1): T63-T70 [37]Chan JL, Heist K, DePaoli AM, et al. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest, 2003, 111(9): 1409-1421 [38]Kelesidis T, Kelesidis I, Chou S, et al. Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications. Ann Intern Med, 2010, 152(2): 93-100 [39]Jung CH, Kim M. Molecular mechanisms of central leptin resistance in obesity. Arch Pharm Res, 2013, 36(2): 201-207 [40]赵申, 骆强. 肥胖儿童血清脂肪细胞因子水平与糖脂代谢微炎症状态的关系. 海南医学院学报, 2016, 22(19): 2335-2338 [41]Weiss R, Taksali SE, Dufour S, et al. The “Obese Insulin-Sensitive” Adolescent: Importance of Adiponectin and Lipid Partitioning. J Clin Endocr Metab, 2005, 90(6): 3731-3737 [42]Straznicky NE, Lambert GW, Masuo K, et al. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. Am J Clin Nutr, 2009, 89(1): 27-36 [43]Kl ting N, Fasshauer M, Dietrich A, et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab, 2010, 299(3): E506-E515 [44]Martínez-Larrad MT, Corbatón Anchuelo A, Del Prado N, et al. Profile of individuals who are metabolically healthy obese using different definition criteria. A population-based analysis in the Spanish population. PLoS One, 2014, 9(9): e106641 [45]Tisdale MJ. Zinc-α2-glycoprotein in cachexia and obesity. Curr Opin Support Palliat Care, 2009, 3(4): 288-293 [46]Liu M, Zhu H, Dai Y, et al. Zinc-α2-glycoprotein is associated with bbesity in Chinese people and HFD-induced obese mice. Front Physiol, 2018, 9:62 [47]Cabassi A, Tedeschi S. Zinc-α2-glycoprotein as a marker of fat catabolism in humans. Curr Opin Clin Nutr Metab Care, 2013, 16(3): 267-271 |